Breaking News Instant updates and real-time market news.

KKR

KKR

$17.04

-0.185 (-1.07%)

, TOSBF

Toshiba, also use TOSYY

$2.03

0.072 (3.68%)

15:03
04/21/17
04/21
15:03
04/21/17
15:03

KKR, INCJ plan offer for Toshiba memory unit, Nikkei reports

KKR (KKR) and the INCJ will tender a joint bid for Toshiba's (TOSBF) memory business that would likely place them in pole position, Nikkei Asian Review reports. The group is expected to participate in a second round of bidding next month after performing due diligence on the unit, the report says. Toshiba partner Western Digital (WDC) and the Development Bank of Japan may take part as well, the report says. Toshiba intends to select a winner before its general shareholders meeting in late June, the report notes. Reference Link

KKR

KKR

$17.04

-0.185 (-1.07%)

TOSBF

Toshiba, also use TOSYY

$2.03

0.072 (3.68%)

TOSYY

Toshiba, also use TOSBF

$12.11

0.385 (3.28%)

WDC

Western Digital

$84.41

1.61 (1.94%)

  • 27

    Apr

  • 27

    Apr

KKR KKR
$17.04

-0.185 (-1.07%)

04/17/17
SBSH
04/17/17
DOWNGRADE
Target $19
SBSH
Neutral
KKR downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded KKR to Neutral and lowered his price target for the shares to $19 from $20.50. The analyst views the stock's valuation relative to peers as less attractive at current levels.
07/07/16
FBCO
07/07/16
INITIATION
Target $16
FBCO
Outperform
KKR reinstated with an Outperform at Credit Suisse
Target $16.
02/02/17
KEYB
02/02/17
NO CHANGE
KEYB
Air Methods sale would 'at least attract initial interest,' says KeyBanc
After The Wall Street Journal reported that Air Methods (AIRM) is in the early stages of selling itself, KeyBanc says that a sale of the company "would at least attract initial interest from both financial and strategic buyers." However, the firm is unsure as to whether a deal would close, given what it sees as Air Methods' "operational challenges." KeyBanc estimates that "a non-strategic buyer" of Air Methods could pay in the low to mid $40s per share for the stock. However, it thinks that Air Medical Group Holdings and KKR could offer a meaningfully higher price, given the $30M-$40M in synergies thatit estimates could be realized by such a deal. KeyBanc raised its price target on Air Methods to $45 from $36 and keeps an Overweight rating on it.
04/17/17
04/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) was downgraded to Equal Weight from Overweight at Morgan Stanley and to Underperform from Market Perform at BMO Capital. 2. Incyte (INCY) downgraded to Neutral from Overweight at Piper Jaffray with analyst Joshua Schimmer citing the complete response letter from the FDA for baricitinib, indicating a need to determine appropriate doses. This setback could take years and lead to approval of only the lower dose, leaving potentially little differentiation from Pfizer's (PFE) rheumatoid arthritis treatment Xeljanz," Schimmer tells investors in a research note. The analyst prefers to wait for a "cleaner entry point" into the shares. 3. KKR (KKR) downgraded to Neutral from Buy at Citi with analyst William Katz saying he views the stock's valuation relative to peers as less attractive at current levels. 4. Monster Beverage (MNST) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Judy Hong saying she expects shares to be range-bound near-term due to soft core Monster sales trends in the US. 5. PNC Financial (PNC) downgraded to Hold from Buy at Rafferty Capital with analyst Richard Bove saying bank stock valuations are too high and growth is lacking. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TOSBF Toshiba, also use TOSYY
$2.03

0.072 (3.68%)

03/17/17
RBCM
03/17/17
NO CHANGE
RBCM
Western Digital likely to acquire Toshiba, says RBC Capital
After multiple media reports stated that the Japanese government probably won;t rescue Toshiba (TOSBF, TOSYY), RBC Capital analyst Amit Daryanani says that the news "greatly increases" the odds of the company being acquired by U.S. entities. He thinks that Western Digital (WDX), in partnership with private equity firms, is the "high probability acquirer" of the company. By undertaking the deal, Western Digital would "further improve its NAND position and drive significant accretion with an upside bias to our $12.00+ EPS scenario," Daryanani wrote. He kept a $90 price target and an Outperform rating on the shares.
01/20/17
DBAB
01/20/17
DOWNGRADE
DBAB
Hold
Toshiba downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Yu Yoshida downgraded Toshiba to Hold citing dilution risk following reports of mounting impairment losses.
02/27/17
MAXM
02/27/17
NO CHANGE
Target $11
MAXM
Buy
Vuzix smart glasses pact with Toshiba a pivotal event, says Maxim
Maxim analyst Brian Kinstlinger noted that Toshiba's (TOSBF) pact with Vuzix (VUZI) for a custom pair of smart glasses based on the recent M300s comes just a year after Toshiba canceled the release of their Wearvue smart glasses and views the deal as validation that Vuzix is a "clear leader" in smart glasses technology. The analyst, who sees the development agreement as a pivotal event for Vuzix, suggests investors buy Vuzix shares ahead of the ramp in revenues he expects in 2017 and reiterates a Buy rating and $11 price target on the stock.
03/31/17
UBSW
03/31/17
NO CHANGE
Target $245
UBSW
Buy
Broadcom deal for Toshiba NAND has wide range of accretion potential, says UBS
UBS analyst Stephen Chin commented on the Nikkei report that Broadcom (AVGO) and Silver Lake Partners had submitted a bid to acquire Toshiba's (TOSBF) NAND business for $17.9B, saying he would not be surprised if Broadcom were in fact a bidder but he is not sure if a deal will happen. Depending on the structure of a deal, his pro forma scenarios range from 3% EPS accretion in FY18 to 9% in FY19 accretion, he tells investors. Chin keeps a Buy rating and $245 price target on Broadcom shares, which slid by 0.6% to close at $220.04 yesterday.
TOSYY Toshiba, also use TOSBF
$12.11

0.385 (3.28%)

WDC Western Digital
$84.41

1.61 (1.94%)

03/10/17
BNCH
03/10/17
NO CHANGE
Target $100
BNCH
Buy
Western Digital recent cloud comments 'hardly worrisome,' says Benchmark
Benchmark analyst Mark Miller attributes recent weakness in Western Digital (WDC) shares to comments made by the company and peer Seagate (STX) at a recent investor conference, with one source indicating that they said a modest pause is expected in cloud demand followed by a 2H17 acceleration. Western Digital COO Mike Cordano, when asked about reports by Intel (INTC) and Hewlett Packard (HPQ) pointing to recent weakness in the traditional data center and server markets, said his company continues to project "solid" 40% annual growth in cloud sales, which he added should be viewed annually, not quarterly, due to short-term dynamics, Miller said. He urges investors to ignore the noise and buy Western Digital, on which he keeps a $100 price target and Buy rating, amid any weakness.
04/11/17
JPMS
04/11/17
UPGRADE
Target $116
JPMS
Overweight
Western Digital upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Rod Hall upgraded Western Digital to Overweight and raised his price target for the shares to $116 from $80. The NAND shortage should boost selling prices while the PC market is stabilizing, Hall tells investors in a research note. He also believes Western Digital has "significant potential" for cost reductions as it realizes synergies from recent acquisitions.
03/28/17
STFL
03/28/17
NO CHANGE
STFL
Western Digital Q3 results likely to beat guidance, says Stifel
Stifel analyst Aaron Rakers expects Western Digital's Q3 results to surpass its guidance, driven by a flash capacity price increase and a positive mix shift. He keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

GE

General Electric

$29.55

-0.72 (-2.38%)

07:26
04/24/17
04/24
07:26
04/24/17
07:26
Periodicals
GE CFO Bornstein concerned over U.S. business confidence, FT reports »

General Electric CFO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 22

    Jun

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

07:25
04/24/17
04/24
07:25
04/24/17
07:25
Recommendations
C.R. Bard, Becton Dickinson analyst commentary  »

C.R. Bard price target…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

07:25
04/24/17
04/24
07:25
04/24/17
07:25
General news
FX Update: The euro surged »

FX Update: The euro…

MTSI

MACOM

$51.74

-0.07 (-0.14%)

, SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

07:24
04/24/17
04/24
07:24
04/24/17
07:24
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$51.74

-0.07 (-0.14%)

SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

NXST

Nexstar

$69.10

0.3 (0.44%)

TRCO

Tribune Media

$37.35

-0.77 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

BUD

AB InBev

$108.28

-0.81 (-0.74%)

07:24
04/24/17
04/24
07:24
04/24/17
07:24
Technical Analysis
AB InBev rallies in early pre-market trading »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$15.57

-0.05 (-0.32%)

, AVXS

AveXis

$76.76

-0.24 (-0.31%)

07:23
04/24/17
04/24
07:23
04/24/17
07:23
Conference/Events
American Academy of Neurology »

69th Annual Meeting of…

ADMS

Adamas Pharmaceuticals

$15.57

-0.05 (-0.32%)

AVXS

AveXis

$76.76

-0.24 (-0.31%)

CATB

Catabasis Pharmaceuticals

$1.45

-0.07 (-4.61%)

MNOV

MediciNova

$5.83

0.08 (1.39%)

IONS

Ionis Pharmaceuticals

$44.26

1.35 (3.15%)

FLKS

Flex Pharma

$3.08

-0.5 (-13.97%)

TGTX

TG Therapeutics

$10.30

-0.15 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 24

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 24

    Aug

VAC

Marriott Vacations

$104.42

1.54 (1.50%)

, WYN

Wyndham

$89.72

-0.03 (-0.03%)

07:22
04/24/17
04/24
07:22
04/24/17
07:22
Recommendations
Marriott Vacations, Wyndham, Extended Stay America analyst commentary  »

A few hotel chanins…

VAC

Marriott Vacations

$104.42

1.54 (1.50%)

WYN

Wyndham

$89.72

-0.03 (-0.03%)

STAY

Extended Stay America

$17.24

-0.07 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 04

    May

CGIX

Cancer Genetics

$4.05

0.1 (2.53%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Hot Stocks
Cancer Genetics launches Complete::IO panel »

Cancer Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$119.10

0.22 (0.19%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Upgrade
Travelers rating change  »

Travelers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLT

FleetCor

$147.66

-2.07 (-1.38%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Recommendations
FleetCor analyst commentary  »

FleetCor should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

DB

Deutsche Bank

$16.50

-0.05 (-0.30%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Technical Analysis
Deutsche Bank rallies sharply in pre-market »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$23.60

-0.2 (-0.84%)

, FCH

Felcor Lodging

$7.32

-0.05 (-0.68%)

07:20
04/24/17
04/24
07:20
04/24/17
07:20
Conference/Events
RLJ Lodging Trust and Felcor Lodging to host joint conference call »

Joint Conference call to…

RLJ

RLJ Lodging Trust

$23.60

-0.2 (-0.84%)

FCH

Felcor Lodging

$7.32

-0.05 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 28

    Apr

AKTX

Akari Therapeutics

$20.50

4.13 (25.23%)

07:16
04/24/17
04/24
07:16
04/24/17
07:16
Hot Stocks
Akari: Interim Phase 2 PNH data demonstrate 'positive' response with Coversin »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

WGO

Winnebago

$26.25

0.15 (0.57%)

07:15
04/24/17
04/24
07:15
04/24/17
07:15
Initiation
Winnebago initiated  »

Winnebago initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$104.89

0.01 (0.01%)

07:14
04/24/17
04/24
07:14
04/24/17
07:14
Periodicals
Chevron to sell Bangladesh gas fields to Himalaya Energy, Reuters says »

Chevron has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

QTS

QTS Realty Trust

$52.90

-0.14 (-0.26%)

07:12
04/24/17
04/24
07:12
04/24/17
07:12
Recommendations
QTS Realty Trust analyst commentary  »

QTS Realty Trust named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CARA

Cara Therapeutics

$16.53

-0.56 (-3.28%)

07:12
04/24/17
04/24
07:12
04/24/17
07:12
Hot Stocks
Cara Therapeutics announces 'positive' data from Phase 1 trial of CR845 »

Cara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

STLD

Steel Dynamics

$35.37

0.46 (1.32%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
Steel Dynamics rating change  »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.72

-0.1 (-1.47%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
AK Steel rating change  »

AK Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

NUE

Nucor

$60.00

-0.35 (-0.58%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
Nucor rating change  »

Nucor upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$30.42

-0.09 (-0.29%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
U.S. Steel rating change  »

U.S. Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

, PPG

PPG

$105.94

-0.43 (-0.40%)

07:09
04/24/17
04/24
07:09
04/24/17
07:09
Hot Stocks
Breaking Hot Stocks news story on AkzoNobel, PPG »

AkzoNobel confirms third…

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

PPG

PPG

$105.94

-0.43 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

SAGE Therapeutics

$72.82

1.19 (1.66%)

07:09
04/24/17
04/24
07:09
04/24/17
07:09
Hot Stocks
SAGE Therapeutics appoints Michael Cloonan as Chief Business Officer »

Sage Therapeutics (SAGE)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOMA

XOMA

$7.73

0.26 (3.48%)

07:09
04/24/17
04/24
07:09
04/24/17
07:09
Hot Stocks
XOMA says X213 shown to be safe and effective in phase 2 study »

XOMA Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

AMDA

Amedica

$0.38

0.01 (2.70%)

07:08
04/24/17
04/24
07:08
04/24/17
07:08
Hot Stocks
Amedica announces regulatory clearance to market, sell Valeo in Australia »

Amedica Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.